Abstract:Background: The exogenous delivery of miRNA to mimic and restore miRNA-34a activity in various cancer models holds significant promise in cancer treatment. Nevertheless, its effectiveness is often impeded by challenges, including a short half-life, propensity for off-target accumulation, susceptibility to inactivation by blood-based enzymes, concerns regarding patient safety, and the substantial cost associated with scaling up. As a means of overcoming these barriers, we propose the development of miRNA-loaded Tat-A86 nanoparticles by virtue of Tat-A86's ability to shield the loaded agent from external environmental factors, reducing degradation and inactivation, while enhancing circulation time and targeted accumulation. Results: Genetically engineered Tat-A86, featuring 16 copies of the interleukin-4 receptor (IL-4R)-binding peptide (AP1), Tat for tumor penetration, and an elastin-like polypeptide (ELP) for presenting target ligands and ensuring stability, served as the basis for this delivery system. Comparative groups, including Tat-E60 and A86, were employed to discern differences in binding and penetration. The designed ELP-based nanoparticle Tat-A86 effectively condensed miRNA, forming stable nanocomplexes under physiological conditions. The miRNA/Tat-A86 formulation bound specifically to tumor cells and facilitated stable miRNA delivery into them, effectively inhibiting tumor growth. The efficacy of miRNA/Tat-A86 was further evaluated using three-dimensional spheroids of lewis lung carcinoma (LLC) as in vitro model and LLC tumor-bearing mice as an in vivo model. It was found that miRNA/Tat-A86 facilitates effective cell killing by markedly improving miRNA penetration, leading to a substantial reduction in the size of LLC spheroids. Compared to other controls, Tat-A86 demonstrated superior efficacy in suppressing the growth of 3D cellular aggregates. Moreover, at equivalent doses, miRNA-34a delivered by Tat-A86 inhibited the growth of LLC cells in allograft mice. Conclusions: Overall, these studies demonstrate that Tat-A86 nanoparticles can deliver miRNA systemically, overcoming the basic hurdles impeding miRNA delivery by facilitating both miRNA uptake and stability, ultimately leading to improved therapeutic effects.

A prostate cancer-targeted polyarginine-disulfide linked PEI nanocarrier for delivery of microRNA

Polymeric Nanostructure Compiled with Multifunctional Components to Exert Tumor-Targeted Delivery of Antiangiogenic Gene for Tumor Growth Suppression

Biologically Responsive Carrier-Mediated Anti-Angiogenesis Shrna Delivery for Tumor Treatment

Programing Assembling/Releasing Multifunctional Mirna Nanomedicine to Treat Prostate Cancer.

In Vitro Studies of Polyethyleneimine Coated Mirna Microspheres As Anticancer Agents

Reducible Self-Assembling Cationic Polypeptide-Based Micelles Mediate Co-Delivery of Doxorubicin and Microrna-34a for Androgen-Independent Prostate Cancer Therapy

A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids

Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.

Second-generation Aptamer-Conjugated PSMA-targeted Delivery System for Prostate Cancer Therapy

A polymeric nanocarrier with a tumor acidity-activatable arginine-rich (R9) peptide for enhanced drug delivery.

A Mesoporous Silica Nanoparticle--pei--fusogenic Peptide System for Sirna Delivery in Cancer Therapy.

Tumor-targeted delivery of SNHG15 siRNA using a ZIF-8 nanoplatform: Towards a more effective prostate cancer therapy

A Novel Fluorinated Polyethyleneimine with Microrna-942-5p-sponges Polyplex Gene Delivery System for Non-Small-cell Lung Cancer Therapy.

Multifunctional elastin-like polypeptide nanocarriers for efficient miRNA delivery in cancer therapy

A novel polyethyleneimine-decorated FeOOH nanoparticle for efficient siRNA delivery

Targeted Delivery of Biodegradable Nanoparticles with Ultrasound-Targeted Microbubble Destruction-Mediated Hvegf-Sirna Transfection in Human PC-3 Cells in Vitro.

Novel Fluorinated Polycationic Delivery of Anti-Vegf Sirna for Tumor Therapy

Self-assembly Nanomicelles Based on Cationic Mpeg-Pla-b-polyarginine(r15) Triblock Copolymer for Sirna Delivery.

GLUT1-mediated Effective Anti-Mirna21 Pompon for Cancer Therapy

Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model

A Cancer Cell Membrane Coated, Doxorubicin and Microrna Co-Encapsulated Nanoplatform for Colorectal Cancer Theranostics